Radiesse 0.8 Reconstitution: A Professional Handling Guide for Clinics

Radiesse 0.8 is a dermal filler and biostimulator composed of synthetic Calcium Hydroxylapatite (CaHA) microspheres suspended in an aqueous gel carrier. Manufactured by Merz in the USA, this product is designed for professional application. It is delivered in a 0.8ml pre-filled syringe, distinct from the larger Radiesse 1.5 presentation. As a biostimulator, it operates differently from hyaluronic acid fillers, focusing on collagen induction over immediate volume. Clinics sourcing such products often look at a wider range of biostimulators and skinboosters to meet diverse professional needs.

Each unit of Radiesse 0.8 typically includes a pre-filled syringe and appropriate needles. Upon receipt, professionals should inspect the packaging for any signs of damage or tampering. Verify the product name, volume (0.8ml), lot number, and expiry date printed on both the outer carton and the syringe label. Ensure the safety seal is intact before proceeding with any preparation. This initial check is a critical step in maintaining product integrity and patient safety.

Before reconstitution, Radiesse 0.8 should be stored according to the manufacturer’s instructions. Typically, this involves storage at controlled room temperature, generally between 15°C to 30°C (59°F to 86°F), away from direct sunlight and freezing temperatures. Adhering to these specifications preserves the product's stability and efficacy. Clinics should maintain meticulous inventory records, including receipt dates and expiry dates, to ensure proper stock rotation and prevent the use of expired materials.

Radiesse 0.8 typically requires reconstitution to achieve desired handling characteristics for professional application. The common diluent used is sterile 0.9% Sodium Chloride (saline). Lidocaine 1% without epinephrine may also be incorporated to enhance patient comfort during application. Typical dilution ratios range from 1:1 to 1:2, meaning 0.8ml of Radiesse would be mixed with 0.8ml to 1.6ml of diluent.

General Reconstitution Steps:

1. Aseptic Technique: Maintain strict aseptic conditions throughout the process.
2. Diluent Preparation: Draw the required volume of sterile saline and/or lidocaine into a separate sterile syringe.
3. Transfer: Slowly inject the diluent into the Radiesse 0.8 syringe. Avoid rapid injection, which can create air bubbles.
4. Mixing: Proceed to the next step for proper suspension.

After introducing the diluent, achieving a homogeneous suspension of the CaHA microspheres is crucial. This is typically accomplished by gently rolling the syringe between the palms for several minutes, or by inverting the syringe slowly back and forth. Avoid vigorous shaking, as this can lead to foaming or aggregation of particles. A properly reconstituted product will appear smooth and uniform. This careful mixing ensures even distribution of the CaHA microspheres for consistent handling characteristics during application. Similar attention to detail is advised when preparing other biostimulators like Sculptra (2 vials).

Radiesse 0.8 is intended for single-patient use immediately after reconstitution. While some manufacturers may provide guidelines for short-term storage of reconstituted product, it is generally recommended to use the product promptly to ensure sterility and optimal rheological properties. Any unused reconstituted product, or any product past its expiry date, must be safely discarded according to clinic protocols and local regulations. This practice aligns with general best practices for injectables like Rejuran Skinbooster 3+3.

For professional integrity and patient safety, sourcing authentic Radiesse 0.8 is paramount. Clinics should purchase products only from authorized and reputable wholesale distributors. Genuine products will have verifiable lot numbers, proper packaging, and often come with certificates of authenticity or proof of cold chain maintenance where applicable. Understanding how to verify genuine Xeomin 200 Units for professional use offers a broader perspective on product verification protocols relevant across different aesthetic injectables. This due diligence protects your practice and ensures you are providing legitimate treatments.